News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Burke & Herbert completed the LINKBANCORP merger, creating ~ $11 billion in assets and declared a $0.55 per share dividend.
  • Glacier Bancorp reported record Q2 net income of $97.9 million, widened net interest margin to 3.90%, and declared a $0.33 quarterly dividend.
  • Phillips Edison raised full-year guidance and received a Moody's outlook upgrade to positive.
  • Financial Institutions reported Q2 net income of $20.8 million ($1.04 diluted) and total loans rose to $4.75 billion.
  • Virtu completed a $500 million incremental first-lien term loan, boosting its senior secured facility to $2.03 billion.
  • VYNE announced a 1-for-50 reverse stock split, paid a special cash dividend, and expects merger closing with Yarrow next week.

Latest Articles

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

The XAI Octagon Floating Rate & Alternative Income Trust announced its monthly common share distribution of $0.225 per share, unchanged from the previous month. The distribution is payable on July 1, 2026, to shareholders of record as of June 15, 2026. The Trust invests primarily in floating rate credit instruments and structured credit investments…

Praxis Precision Medicines Provides Vormatrigine Program Update

Praxis Precision Medicines Provides Vormatrigine Program Update

Praxis Precision Medicines announced that the Phase 2/3 POWER1 study of vormatrigine in patients with focal onset seizures did not meet its primary endpoint of seizure frequency reduction, though a secondary measure of 50% response rate was met and higher dose showed more pronounced seizure reduction. Vormatrigine was generally well-tolerated with …

Microchip Technology Appoints Mitch Little to Its Board of Directors

Microchip Technology Appoints Mitch Little to Its Board of Directors

Microchip Technology Incorporated announced the appointment of Mitch Little, former senior executive at Microchip, to its Board of Directors effective June 1, 2026. Little brings extensive experience in sales, product management, and leadership, and meets Nasdaq's independence requirements. The company highlighted his role in shaping Microchip's cu…

LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance

LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance

LXP Industrial Trust has reported robust leasing performance, completing 4.6 million square feet of leases year-to-date with significant rental rate increases. The company also acquired a prime 37-acre redevelopment site in Phoenix for $103 million, which is fully leased until 2031 and planned for future industrial development. Following these oper…

California Water Service Earns G480 Platinum Certification for Water-Use Efficiency, Conservation Program

California Water Service Earns G480 Platinum Certification for Water-Use Efficiency, Conservation Program

California Water Service (Cal Water) has earned the prestigious G480 Platinum Certification from the Alliance for Water Efficiency, recognizing its leadership in water-use efficiency and conservation program management under the updated G480-25 standard. This achievement highlights Cal Water's commitment to sustainability, high-quality service, and…

Insider Activity and Recent Performance Metrics at CuriosityStream Inc.

Insider Activity and Recent Performance Metrics at CuriosityStream Inc.

The Chief Executive Officer of CuriosityStream Inc., Clinton Larry Stinchcomb, recently purchased a notable amount of the company's common stock. This transaction occurs amidst varying market signals for CuriosityStream (NASDAQ: CURI), including recent reported revenue figures that fell below expectations and strategic announcements regarding conte…

Lee Enterprises Director's Stock Purchases Amid Company Milestones

Lee Enterprises Director's Stock Purchases Amid Company Milestones

Director David Henry Hoffmann, a ten percent owner of Lee Enterprises (LEE), recently executed several transactions acquiring significant quantities of the company's common stock. These purchases occur against a backdrop of positive corporate developments for LEE, including strong second-quarter financial results and a new management agreement with…

UL Solutions Executive Divests Shares Following 10b5-1 Plan; Company Reports Strong Q1 Results and New AI Platform

UL Solutions Executive Divests Shares Following 10b5-1 Plan; Company Reports Strong Q1 Results and New AI Platform

Executive Vice President and Chief Commercial Officer Alberto Uggetti recently sold shares of UL Solutions Class A Common Stock under a pre-arranged trading plan. This transaction occurred against a backdrop of positive corporate news, including strong first quarter 2026 financial results, an announced quarterly dividend, and the launch of new AI p…

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Minerva Neurosciences has established a Scientific Advisory Board (SAB) composed of leading experts in psychiatry and neuroscience to guide the clinical development of roluperidone, an investigational drug targeting negative symptoms of schizophrenia, and to advise on future pipeline programs. The SAB formation fulfills a prior PIPE financing commi…

Merlin, Inc. To Participate in Upcoming Investor Conferences

Merlin, Inc. To Participate in Upcoming Investor Conferences

Merlin, Inc., an aerospace and defense technology company focused on autonomous flight systems, has announced its management will take part in multiple investor conferences throughout June 2026. The events include the Jefferies Defense Tech Summit, ROTH Capital Partners Annual London Conference, and the Maxim Group Defense Tech Conference. The comp…

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Fulcrum Therapeutics announced discontinuation of its pociredir program for sickle cell disease after receiving FDA feedback that raised concerns about the risk of secondary malignancies linked to the drug's target, influenced by a related drug's market withdrawal. Despite positive clinical signals, the FDA sees no viable regulatory path forward. F…